Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence
Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threating iatrogenic
complication of the early luteal phase and/or early pregnancy after in vitro fertilization (IVF) …
complication of the early luteal phase and/or early pregnancy after in vitro fertilization (IVF) …
Assisted reproductive technology and disease management in infertile women with multiple sclerosis
M Sparaco, L Carbone, D Landi, Y Ingrasciotta… - CNS drugs, 2023 - Springer
Multiple sclerosis (MS) predominantly affects women of fertile age. Various aspects of MS
could impact on fertility, such as sexual dysfunction, endocrine alterations, autoimmune …
could impact on fertility, such as sexual dysfunction, endocrine alterations, autoimmune …
[HTML][HTML] Safety and effectiveness of dual trigger (GnRH agonist+ HCG) versus HCG alone in patients with high ovarian response
X Wu, L Yang, H Tang, S Luo, T Tang… - American Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objective: To compare the safety and effectiveness between long-term GnRH agonist plus
HCG (dual trigger) and HCG trigger alone in high ovarian responders. Methods: A …
HCG (dual trigger) and HCG trigger alone in high ovarian responders. Methods: A …
Can we harvest more mature oocytes by repeating gonadotropin-releasing hormone agonist doses in polycystic ovarian syndrome patients at risk of OHSS in …
SH Hashemi, M Hafezi, A Arabipoor… - … Journal of Fertility & …, 2024 - pmc.ncbi.nlm.nih.gov
Background: There is an ongoing debate about the optimal dosage of gonadotropin-
releasing hormone (GnRH) agonist for oocyte triggering in polycystic ovarian syndrome …
releasing hormone (GnRH) agonist for oocyte triggering in polycystic ovarian syndrome …
[PDF][PDF] Can We Harvest More Mature Oocytes by Repeating Gonadotropin-Releasing Hormone Agonist Doses in Polycystic Ovarian Syndrome Patients at Risk of …
SH Hashemi, M Hafezi, A Arabipoor, M Zareei… - International Journal of …, 2024 - ijfs.ir
Background: There is an ongoing debate about the optimal dosage of gonadotropin-
releasing hormone (GnRH) agonist for oocyte triggering in polycystic ovarian syndrome …
releasing hormone (GnRH) agonist for oocyte triggering in polycystic ovarian syndrome …